METTL3 and glioblastoma: YTHDC1 has been shown to promote m6A/METTL3-mediated tumor cell growth in glioblastoma (GBM) via regulation of nonsense-mediated mRNA decay (NMD) of serine- and arginine-rich splicing factors (SRSF) [355].